Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
-776
Closed -$7.5M 157
2017
Q4
$7.5M Buy
+776
New +$73.1K 0.68% 28
2017
Q2
Sell
-714
Closed -$4.65M 217
2017
Q1
$4.65M Sell
714
-464
-39% -$29.2K 0.25% 50
2016
Q4
$7.38M Hold
1,178
0.43% 40
2016
Q3
$7.43M Sell
1,178
-1,169
-50% -$75.7K 0.28% 53
2016
Q2
$14.5M Buy
2,347
+801
+52% +$48.8K 0.76% 26
2016
Q1
$8.83M Sell
1,546
-906
-37% -$50.5K 0.44% 27
2015
Q4
$14.5M Buy
2,452
+180
+8% +$10.4K 0.8% 18
2015
Q3
$12.4M Sell
2,272
-1,432
-39% -$93.2K 0.51% 32
2015
Q2
$24.9M Buy
3,704
+1,820
+97% +$119K 0.91% 19
2015
Q1
$11M Buy
1,884
+1,112
+144% +$67.2K 0.46% 43
2014
Q4
$5.05K Buy
+772
New +$48.7K 0.16% 70
2014
Q3
Sell
-2,712
Closed -$15.3M 255
2014
Q2
$15.3M Sell
2,712
-267
-9% -$14K 0.66% 27
2014
Q1
$15.3M Buy
+2,979
New +$151K 0.86% 29
2013
Q3
Sell
-9,253
Closed -$38.3M 196
2013
Q2
$38.3M Buy
+9,253
New +$405K 2.55% 11

Other funds holding ABBV

Sabby Management's ABBV Position: Q1 2018 in Review

Sabby Management sold out of AbbVie (ABBV) in Q1 2018, closing a stake of 27,559 shares — an estimated $3.03M sold.

Sabby Management first reported a position in ABBV in Q2 2013 and held it in 4 quarters. The position peaked at $14.7M in Q2 2013. 2,015 funds tracked by Wall St. Rank hold ABBV as of Q1 2018.

  • Sabby Management reported no remaining AbbVie position as of Q1 2018 after selling out during the quarter.
  • Sabby Management sold 27,559 AbbVie shares in Q1 2018, an estimated $3.03M.
  • Sabby Management first reported a position in AbbVie in Q2 2013 and held it in 4 quarters.
  • Sabby Management's AbbVie position peaked at $14.7M in Q2 2013.
  • 2,015 funds tracked by Wall St. Rank held AbbVie as of Q1 2018.

Based on Sabby Management's 13F filing for Q1 2018, filed 15 May 2018.